NCT02144870

Brief Summary

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme compared to an alternative treatment which aims at the activation of resources in children and adolescents aged 8 to 18 years with tic disorders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 22, 2014

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

March 16, 2017

Status Verified

March 1, 2017

Enrollment Period

3.7 years

First QC Date

April 14, 2014

Last Update Submit

March 14, 2017

Conditions

Keywords

Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in Symptom Checklist for Tic-Symptoms (FBB-TIC, parent rating) at week 8, 16 and 24

    The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents

    eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)

  • Change in Quality of Life (Tic-HRQoL-FBB)(parent rating)

    The Tic-HRQoL-FBB is used to assess impairment and quality of life through tic symptoms and other comorbid symptoms rated by parents

    eight weeks (T1) and twenty-four weeks (T3)

Secondary Outcomes (8)

  • Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-rating

    eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)

  • Change in Symptom Checklist for Tic-Symptoms, clinical rating

    eight weeks (T1), sixteen weeks (T2) and 24 weeks (T3)

  • Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-rating

    eight weeks (T1), and 24 weeks (T3)

  • Change of comorbid OCD Symptoms (ZWIK-E), parent-rating

    eight weeks (T1), and 24 weeks (T3)

  • Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-rating

    eight weeks (T1), and 24 weeks (T3)

  • +3 more secondary outcomes

Study Arms (2)

Habit Reversal Training

ACTIVE COMPARATOR

At first patients get informed about Tics in general. Then the individual Tics are specified and the tic-reaction is looked at further. The Tic-Symptoms are observed and the premonitory urge is specified. For all individual tics a specific reversal movement is developed. Relaxation methods are introduced.

Behavioral: Habit Reversal Training

Resources activation

ACTIVE COMPARATOR

At first patients get informed about Tics in general. Through different exercises existing resources and skills are activated and strengthened. Feeling of self-esteem and self-respect are strengthened. Also the emotional awareness is strengthened. Relaxation methods are also introduced.

Behavioral: Resources activation

Interventions

awareness training, competing response training

Habit Reversal Training
Resources activation

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years
  • Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2)
  • YGTSS total score F95.2\>13, F95.1\>9
  • Tics are the main problems
  • Intelligence IQ\>80
  • If medication, then has been stable for at least one months in medicated patients
  • No change in medication treatment is planned
  • Ability to participate in weekly outpatient treatment
  • Acceptance of randomization

You may not qualify if:

  • Diagnosis of Autism Spectrum Disorder or Psychosis Parallel continuous psychotherapy of tics or comorbid -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy

Cologne, 50931, Germany

RECRUITING

MeSH Terms

Conditions

TicsTourette Syndrome

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Manfred Döpfner, Prof. Dr.

    Department of Childhood and Adolescent Psychiatry and Psychotherapy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Leading psychologist at the Department of Childhood and Adolescence Psychiatry

Study Record Dates

First Submitted

April 14, 2014

First Posted

May 22, 2014

Study Start

November 1, 2013

Primary Completion

July 1, 2017

Study Completion

September 1, 2017

Last Updated

March 16, 2017

Record last verified: 2017-03

Locations